Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques

被引:17
作者
Moraes, EMP [1 ]
Prímola, NS [1 ]
Hamdan, JS [1 ]
机构
[1] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil
关键词
Cryptococcus neoformans; susceptibility tests;
D O I
10.1046/j.1439-0507.2003.00872.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A total of 64 Cryptococcus neoformans strains, including clinical and environmental Brazilian isolates var. neoformans and var. gattii, were tested for susceptibility to amphotericin B, 5-flucytosine, fluconazole and itraconazole. The tests were performed according to the recommendations of National Committee of Clinical Laboratory Standards and the method of macrodilution in liquid medium of Shadomy et al. [Manual de Microbiologia Clinica, 4th edn. Buenos Aires: Editorial Medica Panamericana, 1987:1229-38]. For most drugs there was a significant difference between the readings taken at 24 and 48 h with both methods. When the minimum inhibitory concentrations obtained by the two techniques were compared, significant differences were observed for amphotericin B and fluconazole. Overall, differences in drug susceptibility with respect to the origin of the isolates or the variety of the fungus were not observed. As an exception, the gattii variety exhibited a high resistance rate to amphotericin B when the technique of Shadomy et al. was applied, a fact possibly related to the greater difficulty for treatment of the disease caused by this fungal variety.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 20 条
[1]   Antifungal resistance trends towards the year 2000 - Implications for therapy and new approaches [J].
Alexander, BD ;
Perfect, JR .
DRUGS, 1997, 54 (05) :657-678
[2]   SUSCEPTIBILITIES OF SERIAL CRYPTOCOCCUS-NEOFORMANS ISOLATES FROM PATIENTS WITH RECURRENT CRYPTOCOCCAL MENINGITIS TO AMPHOTERICIN-B AND FLUCONAZOLE [J].
CASADEVALL, A ;
SPITZER, ED ;
WEBB, D ;
RINALDI, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1383-1386
[3]   INCIDENCE OF POLYENE-RESISTANT YEASTS RECOVERED FROM CLINICAL SPECIMENS [J].
DICK, JD ;
MERZ, WG ;
SARAL, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (01) :158-163
[4]  
Espinel-Ingroff A, 1998, MED MYCOL, V36, P68
[5]   In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs [J].
Franzot, SP ;
Hamdan, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :822-824
[6]   SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS - A MICRODILUTION TECHNIQUE [J].
GHANNOUM, MA ;
IBRAHIM, AS ;
FU, Y ;
SHAFIQ, MC ;
EDWARDS, JE ;
CRIDDLE, RS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2881-2886
[7]  
MENGOLI C, 1991, 1991 INT C AIDS FLOR, P192
[8]   CRYPTOCOCCAL DISEASE OF THE CNS IN IMMUNOCOMPETENT HOSTS - INFLUENCE OF CRYPTOCOCCAL VARIETY ON CLINICAL MANIFESTATIONS AND OUTCOME [J].
MITCHELL, DH ;
SORRELL, TC ;
ALLWORTH, AM ;
HEATH, CH ;
MCGREGOR, AR ;
PAPANAOUM, K ;
RICHARDS, MJ ;
GOTTLIEB, T .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :611-616
[9]   CRYPTOCOCCOSIS IN THE ERA OF AIDS - 100 YEARS AFTER THE DISCOVERY OF CRYPTOCOCCUS-NEOFORMANS [J].
MITCHELL, TG ;
PERFECT, JR .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :515-&
[10]  
MORACE G, 1992, 199I INT C AIDS, P124